To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
TTP LabTech hosts Sample Management Open Day – 3rd August 2010
Read time: Less than a minute
TTP LabTech invites sample management professionals and analytical chemists to attend a Sample Management Open Day at its headquarters near Cambridge, UK on Tuesday 3rd August 2010.
Visitors will be able to find out how to improve efficiency by hearing from those currently working in the field. They will also be able to view TTP LabTech’s sample management products in action and discuss strategies for simplifying sample processing and analysis.
During the day talks will be given by:
• Brian Everatt of Novartis discussing the operational capabilities of TTP LabTech’s Lab2Lab sample management tool,
• James Westcott of Vertex Pharmaceutics covering how their modular TTP LabTech comPOUND and compiler system has grown and developed with the company over the last 5 years,
• Peter Fischer of the University of Nottingham discussing how comPOUND and comPILER fit the university’s approach to sample management and how that differs to that of traditional pharmaceutical companies.
Visitors will be able to find out how to improve efficiency by hearing from those currently working in the field. They will also be able to view TTP LabTech’s sample management products in action and discuss strategies for simplifying sample processing and analysis.
During the day talks will be given by:
• Brian Everatt of Novartis discussing the operational capabilities of TTP LabTech’s Lab2Lab sample management tool,
• James Westcott of Vertex Pharmaceutics covering how their modular TTP LabTech comPOUND and compiler system has grown and developed with the company over the last 5 years,
• Peter Fischer of the University of Nottingham discussing how comPOUND and comPILER fit the university’s approach to sample management and how that differs to that of traditional pharmaceutical companies.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
